Romero LD, Hernández FJJ

Language: Spanish
References: 14
Page: 33-35
PDF size: 130.44 Kb.

Text Extraction

No Abstract

REFERENCES

1. Ubrbaniak SJ, Greiss MA. RhD hemolytic disease of the fetus and the newborn. Blood Reviews 2000; 14:44-61.

2. 2. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical practice. Teenth edition. Oxford, UK: Blackwell Scientific Publication; 1997.

3. 3. American Academy of Pediatrics. Clinical practice guideline. Pediatrics 2004;114:1.

4. 4. Linares J. Inmunohematología y transfusión, princi-pios y procedimientos. Caracas, Venezuela: Cromotip; 1986. p. 253-284.

5. 5. Oski FA, Naiman JL. Hematological problems in the newborn. En: Mayor problems in clinical pediatrics. Philadelphia, USA: WB Saunders Company; 1996. p. 455-461.

6. 6. Judd WJ, Scientific Section Coordinating Committee of the AABB. Practice Guidelines for prenatal and perinatal immunohematology, revised. Transfusion 2001; 41:1445-52.

7. 7. Robson SC, Lee D, Urbanik S: Anti-D immunoglo-bulin in RhD prophylaxix. Br J Obstet Gynaecol 1998; 105:129.

8. 8. Diamond Lk, Blackfan KD, Batty JM. Erithro-blastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn. J Pediatric 1932;1:269-309.

9. 9. Bowman JM. The prevention of Rh inmmunization. Trans Med Rev 1988;2:129-150

10. Maisels MJ, Watchko. Treatment of jaundice in low birthweight infants. 2003. p. 459-463

11. Naulaeres G, Barten S, Vanhole C, et al. Management of severe neonatal anemia due to fetomaternal trans-fusion. Am J Perinatol 1999;16:193.

12. Manejo de la hiperbilirrubinemia en el recién nacido de término sano. Pediatrics 1994;94:558-565

13. Hammerman G, Kaplan M. Recent developments in the management of neonatal hyperbilirrubinemia. Neo Reviews 2000;1:25-31

14. Lee D, Contreras M, Robson SC, et al. Recommenda-tions for the use of anti-D immunoglobulin for Rh prophylaxis. Transfusion Medicine 1999;9:93-97.